• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在不断变化的英国国民医疗服务体系中提供门诊肠外抗菌治疗(OPAT):益处、障碍与机遇

Delivery of Outpatient Parenteral Antimicrobial Therapy (OPAT) in an Ever-Changing National Health Service (UK): Benefits, Barriers, and Opportunities.

作者信息

Durojaiye Oyewole Christopher, Fiori Charlotte, Cartwright Katharine

机构信息

Department of Infection and Tropical Medicine, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield S10 2JF, UK.

OPAT Unit, University Hospitals of Derby and Burton NHS Foundation Trust, Derby DE22 3NE, UK.

出版信息

Antibiotics (Basel). 2025 Apr 29;14(5):451. doi: 10.3390/antibiotics14050451.

DOI:10.3390/antibiotics14050451
PMID:40426518
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12108282/
Abstract

Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used to manage a broad range of infections, enabling patients to receive intravenous antibiotics safely outside inpatient settings. In this review, we examine the current landscape of OPAT practice across the United Kingdom (UK), assessing its clinical, economic, and operational impact. The benefits of OPAT for patients and the National Health Service (NHS), as well as its associated risks, are discussed. Additionally, we explore the challenges hindering its broader implementation within the UK. Finally, we highlight recent innovations and emerging applications of OPAT relevant to the NHS, underscoring key considerations for its future expansion and emphasising the need for a nationally coordinated strategy to realise its full potential.

摘要

门诊胃肠外抗菌治疗(OPAT)越来越多地用于管理多种感染,使患者能够在非住院环境中安全地接受静脉抗生素治疗。在本综述中,我们审视了英国门诊胃肠外抗菌治疗(OPAT)的当前实践情况,评估其临床、经济和运营影响。讨论了门诊胃肠外抗菌治疗(OPAT)对患者和国民医疗服务体系(NHS)的益处及其相关风险。此外,我们探讨了阻碍其在英国更广泛实施的挑战。最后,我们强调了与国民医疗服务体系(NHS)相关的门诊胃肠外抗菌治疗(OPAT)的近期创新和新兴应用,强调其未来扩展的关键考虑因素,并强调需要制定全国协调战略以充分发挥其潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3761/12108282/da76157eafc3/antibiotics-14-00451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3761/12108282/da76157eafc3/antibiotics-14-00451-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3761/12108282/da76157eafc3/antibiotics-14-00451-g001.jpg

相似文献

1
Delivery of Outpatient Parenteral Antimicrobial Therapy (OPAT) in an Ever-Changing National Health Service (UK): Benefits, Barriers, and Opportunities.在不断变化的英国国民医疗服务体系中提供门诊肠外抗菌治疗(OPAT):益处、障碍与机遇
Antibiotics (Basel). 2025 Apr 29;14(5):451. doi: 10.3390/antibiotics14050451.
2
Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses.英国的门诊患者的肠外抗菌治疗(OPAT)与住院治疗:针对六个关键诊断的健康经济评估。
BMJ Open. 2021 Sep 28;11(9):e049733. doi: 10.1136/bmjopen-2021-049733.
3
Outpatient parenteral antimicrobial therapy and antimicrobial stewardship: challenges and checklists.门诊胃肠外抗菌治疗与抗菌管理:挑战与清单
J Antimicrob Chemother. 2015 Apr;70(4):965-70. doi: 10.1093/jac/dku517. Epub 2014 Dec 23.
4
Best practices, implementation and challenges of outpatient parenteral antimicrobial therapy: results of a worldwide survey among healthcare providers.门诊胃肠外抗菌治疗的最佳实践、实施与挑战:医疗服务提供者的全球调查结果
Ther Adv Infect Dis. 2023 Dec 13;10:20499361231214901. doi: 10.1177/20499361231214901. eCollection 2023 Jan-Dec.
5
Recent innovations and new applications of outpatient parenteral antimicrobial therapy.近期门诊患者的肠外抗菌治疗的创新和新应用。
Expert Rev Anti Infect Ther. 2021 Jan;19(1):55-64. doi: 10.1080/14787210.2020.1810566. Epub 2020 Dec 17.
6
Clinical efficacy, cost analysis and patient acceptability of outpatient parenteral antibiotic therapy (OPAT): a decade of Sheffield (UK) OPAT service.门诊静脉用抗生素治疗 (OPAT) 的临床疗效、成本分析和患者接受度:谢菲尔德(英国)OPAT 服务十年来的经验。
Int J Antimicrob Agents. 2018 Jan;51(1):26-32. doi: 10.1016/j.ijantimicag.2017.03.016. Epub 2017 Jun 30.
7
A qualitative study of patients' feedback about Outpatient Parenteral Antimicrobial Therapy (OPAT) services in Northern England: implications for service improvement.一项关于英格兰北部患者对门诊肠外抗菌治疗(OPAT)服务反馈的定性研究:对服务改进的启示
BMJ Open. 2018 Jan 10;8(1):e019099. doi: 10.1136/bmjopen-2017-019099.
8
A Qualitative Review of Patient Feedback for the OPAT (Outpatient Antimicrobial Therapy) Service in Bristol.布里斯托尔门诊抗菌治疗(OPAT)服务患者反馈的定性综述
Antibiotics (Basel). 2024 May 3;13(5):420. doi: 10.3390/antibiotics13050420.
9
Clinical efficacy and cost-effectiveness of outpatient parenteral antibiotic therapy (OPAT): a UK perspective.门诊静脉用抗生素治疗(OPAT)的临床疗效和成本效益:英国视角。
J Antimicrob Chemother. 2009 Dec;64(6):1316-24. doi: 10.1093/jac/dkp343. Epub 2009 Sep 19.
10
Outpatient parenteral antimicrobial therapy in a changing NHS: challenges and opportunities.在不断变化的国民保健制度下的门诊患者的抗感染治疗:挑战与机遇。
Clin Med (Lond). 2013 Feb;13(1):35-6. doi: 10.7861/clinmedicine.13-1-35.

本文引用的文献

1
Hospital admission avoidance in a London NHS trust: a retrospective review of King's OPAT service.伦敦一家国民保健服务信托机构的住院避免情况:对国王学院门诊病人家庭治疗服务的回顾性研究
Br J Nurs. 2025 Apr 3;34(7):S4-S12. doi: 10.12968/bjon.2024.0485.
2
The environmental impact of intravenous antimicrobial therapies: a comparison of OPAT and inpatient administration care pathways.静脉抗菌治疗的环境影响:门诊抗菌治疗(OPAT)与住院给药护理途径的比较
JAC Antimicrob Resist. 2025 Mar 11;7(2):dlaf030. doi: 10.1093/jacamr/dlaf030. eCollection 2025 Apr.
3
Organisational quality and hospital pharmacists' roles of outpatient parenteral antimicrobial therapy (OPAT) in Belgian hospitals: a national survey.
比利时医院门诊肠外抗菌治疗(OPAT)的组织质量与医院药剂师的作用:一项全国性调查。
Acta Clin Belg. 2024 Oct;79(5):341-349. doi: 10.1080/17843286.2024.2448357. Epub 2025 Jan 11.
4
Midline vs Peripherally Inserted Central Catheter for Outpatient Parenteral Antimicrobial Therapy.门诊肠外抗菌治疗中使用中线导管与外周静脉穿刺中心静脉导管的比较。
JAMA Intern Med. 2025 Jan 1;185(1):83-91. doi: 10.1001/jamainternmed.2024.5984.
5
Malfunctions of Non-Electrical Infusion Pumps.非电动输液泵故障
Dtsch Arztebl Int. 2024 Aug 9;121(16):541-542. doi: 10.3238/arztebl.m2024.0082.
6
Outpatient parenteral antimicrobial therapy (OPAT) across the world: a comparative analysis-what lessons can we learn?全球门诊胃肠外抗菌治疗(OPAT):一项比较分析——我们能学到什么经验教训?
JAC Antimicrob Resist. 2024 Jul 19;6(4):dlae111. doi: 10.1093/jacamr/dlae111. eCollection 2024 Aug.
7
Safety and efficacy of outpatient parenteral antimicrobial therapy: A systematic review and meta-analysis of randomized clinical trials.门诊患者的肠外抗菌治疗的安全性和疗效:一项随机临床试验的系统评价和荟萃分析。
Int J Antimicrob Agents. 2024 Aug;64(2):107263. doi: 10.1016/j.ijantimicag.2024.107263. Epub 2024 Jul 2.
8
Making a case for outpatient parenteral antimicrobial therapy (OPAT).倡导门诊患者的肠外抗菌治疗(OPAT)。
J Antimicrob Chemother. 2024 Aug 1;79(8):1723-1724. doi: 10.1093/jac/dkae183.
9
Current practices and challenges of outpatient parenteral antimicrobial therapy: a narrative review.门诊患者的肠外抗菌治疗的现状和挑战:叙事性综述。
J Antimicrob Chemother. 2024 Sep 3;79(9):2083-2102. doi: 10.1093/jac/dkae177.
10
Clinical outcomes in OPAT patients treated with ceftriaxone 4 g and ceftazidime 6 g extended interval dosing regimens.接受头孢曲松4g和头孢他啶6g延长给药间隔方案治疗的门诊抗菌药物治疗患者的临床结局
JAC Antimicrob Resist. 2024 May 30;6(3):dlae079. doi: 10.1093/jacamr/dlae079. eCollection 2024 Jun.